Device Dentistry

Moc24

Payments companies reported to CMS as associated with Moc24. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,158associated payments (2023-2025)

18clinicians with associated payments

1company reporting

By year

2024 $1,158

Payments reported as associated with Moc24, per program year, as reported to CMS.

Who makes it

Meisinger USA, LLC $1,158 associated with Moc24 (2023-2025)

Specialties most often involved

General Practice (Dentist) $644

Dentist $450

Endodontics $64.35

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Moc24

These are the largest totals companies reported as associated with Moc24. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Carly Schrade	Louisville, CO	General Practice (Dentist)	$64.35
Bryce Reiser	Denver, CO	Dentist	$64.35
Geebellue Mensah	Brighton, CO	General Practice (Dentist)	$64.35
Jane Yang	New York, NY	General Practice (Dentist)	$64.35
Hammad Zaheer	Aurora, CO	General Practice (Dentist)	$64.35
Allison Brown	Glenwood Springs, CO	Endodontics	$64.35
Lindsey Shall	Effingham, IL	Dentist	$64.35
Sheila Stille	Aurora, CO	General Practice (Dentist)	$64.35
Dustin Ebner	Wheat Ridge, CO	General Practice (Dentist)	$64.35
Matthew Chapman	Pueblo, CO	General Practice (Dentist)	$64.35

Prescribed Moc24?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.